Ramsay Health Care Limited (ASX: RHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ramsay Health Care Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Ramsay Health Care Limited (ASX: RHC)
Latest News

a woman
⏸️ Investing

3 reasons to buy Ramsay Health Care Limited shares today

Here’s why I think Ramsay Health Care Limited (ASX:RHC) deserves a place in your portfolio.

Read more »

a woman
⏸️ Investing

4 BIG share market winners from China's growing middle class

New research points to China becoming a middle class society by 2030. Bellamy's Australia Ltd (ASX:BAL) is one of four…

Read more »

a woman
⏸️ Investing

Top stock picks for November

Henderson Group plc (ASX:HGG), National Australia Bank Ltd. (ASX:NAB) and Reject Shop Ltd (ASX:TRS) are among November's top picks.

Read more »

a woman
⏸️ Investing

Ramsay Health Care Limited reaffirms guidance, is time to buy shares?

After a sharp drop in its share price recently does today’s announcement make Ramsay Health Care Limited (ASX:RHC) a bargain…

Read more »

a woman
⏸️ Investing

CRASH: Should you buy shares of Healthscope Ltd?

Healthscope Ltd (ASX:HSO) shares have plummeted 23% since Friday.

Read more »

a woman
⏸️ Investing

CRASH: Is Ramsay Health Care Limited a buy at this share price?

Ramsay Health Care Limited (ASX:RHC) shares have been hammered in the last month. Is it time to buy its shares?

Read more »

a woman
⏸️ Investing

How to avoid one simple investing mistake that could cost you thousands

Think an ageing population will make you a millionaire? Don't be so sure.

Read more »

a woman
⏸️ Investing

How to build a portfolio of growing dividend payments

Ramsay Health Care Limited (ASX:RHC), InvoCare Limited (ASX:IVC) and Washington H. Soul Pattinson and Co (ASX:SOL) could be the dividend…

Read more »

a woman
⏸️ Investing

Is it too late to buy Pulse Health Limited shares?

The takeover offer for Pulse Health Limited (ASX:PHG) could be an opportunity for investors to make a quick win.

Read more »

a woman
⏸️ Investing

Why the Pulse Health Limited share price soared today

Pulse Health Limited (ASX:PHG) soars on takeover offer

Read more »

a woman
⏸️ Investing

3 growth shares to buy for a healthy portfolio 

Why Healthscope Ltd (ASX:HSO), Ramsay Health Care Ltd (ASX:RHC) and Medibank Private Ltd (ASX:MPL) would be great additions to any portfolio.  

Read more »

a woman
⏸️ Investing

Is it time to buy CSL Limited shares?

Is CSL Limited (ASX: CSL) now overvalued following its share price gain?

Read more »

Frequently Asked Questions

Yes, Ramsay Health Care has historically paid two fully franked dividends a year.

Ramsay Health Care generally pays its shareholder dividends in March and September. 

Ramsay Health Care Ltd listed on the ASX on 24 September 1997.

RHC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Ramsay Health Care Limited

Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.

It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.

The vast majority of the company's revenue is generated from its Australian and European operations.

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
26 Mar 2026 Steven Sargent Buy 619 $24,979
On-market trade.
25 Mar 2026 Craig Drummond Buy 15,000 $602,788
On-market trade. average price per ordinary share
24 Mar 2026 Karen Penrose Buy 701 $27,625
On-market trade.
15 Dec 2025 Natalie Davis Issued 74,075 $2,618,551
Issue of securities. 131,547 Performance Rights
26 Nov 2025 Natalie Davis Issued 21,071 $675,011
Director remuneration. VWAP

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr David Ingle Thodey Non-Executive DirectorNon-Executive Chairman Nov 2017
Mr Thodey is a business leader focused on innovation, technology, digital transformation, and corporate governance, with more than 40 years of experience. In addition to being Chair he is currently Chair of Xero Limited, Chancellor the University of Sydney, and co-Chair of the Great Barrier Reef Foundation. He is also a non-executive member of the Reserve Bank of Australia Governance Board. He is Chair of Governance Committee.
Ms Catriona Alison Deans Non-Executive Director Nov 2018
Ms Deans has 25 years of experience building technology-enabled businesses involved in media, ecommerce, financial services, and health, and across leadership roles as an executive, a director and in venture capital. She is also Chair of Cochlear Limited, Chair of Calix Limited and a Non-Executive Director of Fitness Passport, The Observership Program and Deputy Pty Ltd. She is also a Venture Partner of Main Sequence Ventures. In her executive career, she was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas and most recently CEO of Netus Pty Ltd (a technology investment company acquired by Fairfax). She also spent seven years as a consultant with McKinsey and Company. She is also a member of Governance Committee.
Mr Michael Stanley Siddle Non-Executive Director May 1975
Mr Siddle has experience in the management of private hospitals and has been involved in expansion through developments, mergers and acquisitions. He is also member of Governance Committee.
Mr Craig Milton Drummond Non-Executive Director Jul 2025
Mr Drummond brings executive and board-level experience across healthcare, financial services, and other regulated industries. He is also Chair of Transurban Group, Chair of the Australian Foundation Investment Company Limited, and Chair of The Ian Potter Foundation. He has previously served as President and Director of the Geelong Football Club Ltd, a Director of the Florey Institute of Neuroscience and Mental Health, and a Member of the Federal Government's Financial Regulator Assessment Authority. His executive career includes five years as Chief Executive Officer of Medibank Private Ltd (2016-2021). He was formerly Group Executive Finance and Strategy at National Australia Bank, and Chief Executive Officer and Country Head at Bank of America Merrill Lynch (Australia).
Ms Helen Kurincic Non-Executive Director Mar 2024
Ms Kurincic is member of Risk Management Committee. She brings operational, executive and board-level experience in a range of Australian based healthcare organisations. In addition to serving on the Ramsay Board, she is currently Chair of McMillan Shakespeare and a director of Carlton Football Club. Her previous health sector roles include Non-Executive Director of private health insurer HBF Health, Estia Health, Integral Diagnostics (Chair), Sirtex Medical, Domain Principal Group, public hospital service provider Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group.
Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
Ms Penrose is member of Risk Management Committee. She has had an executive career in leadership and CFO roles, in financial services. She has experience in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She has been a full-time director since 2014 and is a committee chair of audit and risk.
Mr Steven Andrew Sargent Non-Executive Director Nov 2021
Mr Sargent is Chair of Risk Management Committee. His executive career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe, and Asia Pacific. In addition to being a Non-Executive Director of Ramsay, he also serves as a Director of Ramsay Generale de Sante and is the Chair of infection prevention company Nanosonics Limited. His unlisted board activities include Chairman of The Origin Foundation Limited, Origin's philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.
Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
Ms Dyckerhoff brings expertise in market growth strategies, business development and operational performance improvement in hospitals. She has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, she transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She is member of Risk Management Committee.
Mr Natalie Davis Chief Executive OfficerManaging Director Dec 2024
Ms Davis has experience driving strategic transformation, customer focus and growth. She joined Ramsay after a decade with the Woolworths Group, where she held several roles including as Managing Director of Woolworths Supermarkets, Chief Customer Transformation Officer and Managing Director Woolworths NZ.
Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
-
Michael Hirner Acting Group Executive Finance
-
Henrietta Rowe Company SecretaryGroup General Counsel
-
Brindan Suresh Group Executive Health and Strategy
-
Colleen Harris Group Executive People and Sustainability
-
Pascal Roche Managing Director Ramsay Sante
-
Nick Costa Managing Director UK Hospitals Acting Managing Director Elysium
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 48,815,874 21.15%
J P Morgan Nominees Australia Pty Limited 36,515,720 15.82%
Netwealth Investments Limited <Wrap Services A/C> 33,792,188 14.64%
Paul Ramsay Holdings Pty Limited 22,346,876 9.68%
Citicorp Nominees Pty Limited 8,187,680 3.55%
National Nominees Limited 7,230,630 3.13%
Woolwich Investments Pty Ltd <The Siddle Family Trust> 3,238,259 1.40%
BNP Paribas Noms Pty Ltd 3,147,220 1.36%
Washington H Soul Pattinson And Company Limited 2,758,806 1.20%
BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,750,000 1.19%
Argo Investments Limited 2,747,673 1.19%
BNP Paribas Nominees Pty Ltd <Agency Lending Collateral > 2,721,314 1.18%
Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 2,057,299 0.89%
Custodial Services Limited <Beneficiaries Holding A/C> 1,028,000 0.45%
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 780,296 0.34%
BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 721,395 0.31%
HSBC Custody Nominees (Australia) Limited Gsi Eda 710,830 0.31%
Australian Foundation Investment Company Limited 625,740 0.27%
UBS Nominees Pty Ltd 575,000 0.25%
Certane Ct Pty Ltd <Ramsay Unallocated Ac> 574,899 0.25%

Profile

since

Note